e-learning
resources
Virtual 2020
Pre-Congress Content
COPD phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Czech national alpha-1 antitrypsin registry
J. Chlumsky (Praha 4, Czech Republic), K. Kusalova (Brno, Czech Republic)
Source:
Virtual Congress 2020 – COPD phenotypes
Session:
COPD phenotypes
Session type:
E-poster session
Number:
2440
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chlumsky (Praha 4, Czech Republic), K. Kusalova (Brno, Czech Republic). Czech national alpha-1 antitrypsin registry. 2440
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004
The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
A well-designed/conducted study on alpha-1 antitrypsin epidemiology not quoted
Source: Eur Respir J, 51 (3) 1702662; 10.1183/13993003.02662-2017
Year: 2018
Rare alpha-1 antitrypsin mutations in the Irish population
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012
Rare alpha-1 antitrypsin mutations in the Irish population
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011
Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
Research priorities in alpha-1 antitrypsin deficiency (AATD) for healthcare professionals
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency
Source: Eur Respir J, 53 (2) 1900138; 10.1183/13993003.00138-2019
Year: 2019
Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Prevalence of alpha-1 antitrypsin deficiency (AATD) in Greater Glasgow and Clyde (GG&C) and current practises
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Alpha1-antitrypsin deficiency in Italy: Analysis of the Italian registry database
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept